Skip to main content
OpenTrials

Clinical trial condition

NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations

Explore clinical trials studying NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations trial results

Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

NCT04641442

Conditions
Digestive System Diseases, Enterocolitis, Gastroenteritis, +4 more
Locations
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
  • Children´s Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children´s Hospital Houston, Texas, United States
  • Seattle Children´s Hospital Seattle, Washington, United States
View Trial Details

Related conditions